The influence of latent viral infection on rate of cognitive decline over 4 years

Journal of the American Geriatrics Society

Volumn 54, Issue 7, 2006, Pages 1046-1054

  Aiello, Allison E ^a   Haan, Mary N ^b   Blythe, Lynn ^b   Moore, Kari ^b   Gonzalez, Jeffrey M ^b   Jagust, William ^c  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Community; Dementia; Elderly; Herpes; Rate of cognitive decline

Indexed keywords

C REACTIVE PROTEIN; CYTOMEGALOVIRUS ANTIBODY; HERPES SIMPLEX VIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; EDUCATION; FEMALE; HEALTH STATUS; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE RESPONSE; INCOME; LATENT VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; PROSPECTIVE STUDY; RECALL; SEX; VIRUS REACTIVATION;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; C-REACTIVE PROTEIN; CALIFORNIA; COGNITION DISORDERS; CYTOMEGALOVIRUS INFECTIONS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EFFECT MODIFIERS (EPIDEMIOLOGY); FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOGLOBULIN G; MALE; MEXICAN AMERICANS; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 33745621303     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2006.00796.x     Document Type: Article

References (76)

1. Ernst RL, Hay JW. The U.S. economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994;84:1261-1264.
2. Connell CM, Janevic MR, Gallant MP. The costs of caring: Impact of dementia on family caregivers. J Geriatr Psychiatry Neurol 2001;14:179-187.
3. Chang CY, Silverman DH. Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease. Expert Rev Mol Diagn 2004;4:63-69.
4. Tilvis RS, Kahonen-Vare MH, Jolkkonen J et al. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 2004;59A:M268-M274.
5. Yaffe K, Lindquist K, Penninx BW et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003;61:76-80.
6. Weaver JD, Huang MH, Albert M et al. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002;59:371-378.
7. Itzhaki RF, Wozniak MA, Appelt DM et al. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 2004;25:619-627.
8. Ringheim GE, Conant K. Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections). J Neuroimmunol 2004;147:43-49.
9. Almanzar G, Schwaiger S, Jenewein B et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005;79:3675-3683.
10. Haan MN, Mungas DM, Gonzalez HM et al. Prevalence of dementia in older latinos: The influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc 2003;51:169-177.
11. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York: Springer-Verlag, 2000.
12. Osborne J. Notes on the use of data transformations. Pract Assess Res Eval 2002;8:1-7.
13. Ritchie K, Lovestone S. The dementias. Lancet 2002;360:1759-1766.
14. Kohout FJ, Berkman LF, Evans DA et al. Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health 1993;5:179-193.
15. Wilson RS, Beckett LA, Barnes LL et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-193.
16. Glaser R, Pearson GR, Jones JF et al. Stress-related activation of Epstein-Barr virus. Brain Behav Immun 1991;5:219-232.
17. Strandberg TE, Pitkala KH, Linnavuori KH et al. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke 2003;34:2126-2131.
18. Rothenbacher D, Brenner H, Hoffmeister A et al. Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: Role of confounding and reference group. Atherosclerosis 2003;170:339-345.
19. de Jong MD, Galasso GJ, Gazzard B et al. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res 1998;39:141-162.
20. Xu F, Schillinger JA, Sternberg MR et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis 2002;185:1019-1024.
21. Schor JD, Levkoff SE, Lipsitz LA et al. Risk factors for delirium in hospitalized elderly. JAMA 1992;267:827-831.
22. Murray AM, Levkoff SE, Wetle TT et al. Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol 1993;48:M181-M186.
23. Rockwood K, Cosway S, Carver D et al. The risk of dementia and death after delirium. Age Ageing 1999;28:551-556.
24. Pawelec G, Akbar A, Caruso C et al. Is immunosenescence infectious? Trends Immunol 2004;25:406-410.
25. Nilsson BO, Ernerudh J, Johansson B et al. Morbidity does not influence the T-cell immune risk phenotype in the elderly: Findings in the Swedish NONA Immune Study using sample selection protocols. Mech Ageing Dev 2003;124:469-476.
26. Looney RJ, Falsey A, Campbell D et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999;90:213-219.
27. Wikby A, Ferguson F, Forsey R et al. An immune risk phenotype, cognitive impairment, and survival in very late life: Impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 2005;60A:M556-M565.
28. Ouyang Q, Wagner WM, Zheng W et al. Dysfunctional CMV-specific CD8 (+) T cells accumulate in the elderly. Exp Gerontol 2004;39:607-613.
29. Ouyang Q, Wagner WM, Wikby A et al. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol 2003;23:247-257.
30. Khan N, Shariff N, Cobbold M et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002;169:1984-1992.
31. Trzonkowski P, Mysliwska J, Szmit E et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of antihemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 2003;21:3826-3836.
32. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004;39:687-699.
33. Schmaltz HN, Fried LP, Xue QL et al. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc 2005;53:747-754.
34. Deatly AM, Haase AT, Fewster PH et al. Human herpes virus infections and Alzheimer's disease. Neuropathol Appl Neurobiol 1990;16:213-223.
35. Lin WR, Wozniak MA, Wilcock GK et al. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis 2002;9:82-87.
36. Lin WR, Wozniak MA, Cooper RJ et al. Herpesviruses in brain and Alzheimer's disease. J Pathol 2002;197:395-402.
37. Jamieson GA, Maitland NJ, Wilcock GK et al. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol 1992;167:365-368.
38. Lin WR, Shang D, Wilcock GK et al. Alzheimer's disease, herpes simplex virus type 1, cold sores and apolipoprotein E4. Biochem Soc Trans 1995;23:594S.
39. Lin WR, Shang D, Itzhaki RF. Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease. Mol Chem Neuropathol 1996;28:135-141.
40. Itzhaki RF, Lin WR, Shang D et al. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997;349:241-244.
41. Itabashi S, Arai H, Matsui T et al. Herpes simplex virus and risk of Alzheimer's disease. Lancet 1997;349:1102.
42. Beffert U, Stolt PC, Herz J. Functions of lipoprotein receptors in neurons. J Lipid Res 2004;45:403-409.
43. Hemling N, Roytta M, Rinne J et al. Herpesviruses in brains in Alzheimer's and Parkinson's diseases. Ann Neurol 2003;54:267-271.
44. Itzhaki RF, Wozniak MA. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: A dangerous liaison in Alzheimer's disease and other disorders. Prog Lipid Res 2006;45:73-90.
45. Ravaglia G, Forti P, Maioli F et al. The clock-drawing test in elderly Italian community dwellers: Associations with sociodemographic status and risk factors for vascular cognitive impairment. Dement Geriatr Cogn Disord 2003;16:287-295.
46. Teunissen CE, van Boxtel MP, Bosma H et al. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 2003;134:142-150.
47. Engelhart MJ, Geerlings MI, Meijer J et al. Inflammatory proteins in plasma and the risk of dementia: The Rotterdam Study. Arch Neurol 2004;61:668-672.
48. Duong T, Acton PJ, Johnson RA. The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions. Brain Res 1998;813:303-312.
49. Duong T, Nikolaeva M, Acton PJ. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res 1997;749:152-156.
50. Iwamoto N, Nishiyama E, Ohwada J et al. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci Lett 1994;177:23-26.
51. Lannergard A, Larsson A, Kragsbjerg P et al. Correlations between serum amyloid A protein and C-reactive protein in infectious diseases. Scand J Clin Lab Invest 2003;63:267-272.
52. Nakayama T, Sonoda S, Urano T et al. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem 1993;39:293-297.
53. Hyams KC, Cross ER, Bianco MA et al. Geographic risk factors for viral hepatitis and cytomegalovirus infection among United States Armed Forces blood donors. Transfusion 1992;32:644-647.
54. White NH, Yow MD, Demmler GJ et al. Prevalence of cytomegalovirus antibody in subjects between the ages of 6 and 22 years. J Infect Dis 1989;159:1013-1017.
55. Pulliam L, Moore D, West DC. Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: Possible role in neurotoxicity. J Neurovirol 1995;1:219-227.
56. Perkins P, Annegers JF, Doody RS et al. Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology 1997;49:44-50.
57. Tang MX, Cross P, Andrews H et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001;56:49-56.
58. Clark CM, DeCarli C, Mungas D et al. Earlier onset of Alzheimer disease symptoms in Latino individuals compared with Anglo individuals. Arch Neurol 2005;62:774-778.
59. Ringman JM, Flores DL. Earlier Alzheimer onset in Latino persons: Ethnic difference vs selection bias. Arch Neurol 2005;62:1786-1787.
60. Rivera VM. The terms Latino and Anglo and tendency to early Alzheimer disease. Arch Neurol 2005;62:1787, author reply 1787-1788.
61. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990;69:19-36.
62. Goade DE, Nofchissey RA, Kusewitt DF et al. Ultraviolet light induces reactivation in a murine model of cutaneous herpes simplex virus-1 infection. Photochem Photobiol 2001;74:108-114.
63. Glaser R, Kiecolt-Glaser JK. Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Ann Behav Med 1997;19:78-82.
64. Rawls W. Herpes simplex virus. In: Fields BN, ed. Virology. New York: Raven Press, 1985.
65. Biondi M, Zannino LG. Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animals and man: A review. Psychother Psychosom 1997;66:3-26.
66. Sainz B, Loutsch JM, Marquart ME et al. Stress-associated immunomodulation and herpes simplex virus infections. Med Hypotheses 2001;56:348-356.
67. Keller JN. Age-related neuropathology, cognitive decline, and Alzheimer's disease. Ageing Res Rev 2006;5:1-13.
68. Wilson RS, Bennett DA, Mendes de Leon CF et al. Distress proneness and cognitive decline in a population of older persons. Psychoneuroendocrinology 2005;30:11-17.
69. Leonard BE. Changes in the immune system in depression and dementia: Causal or co-incidental effects? Int J Dev Neurosci 2001;19:305-312.
70. Mitchell AJ. Depression as a risk factor for later dementia: A robust relationship? Age Ageing 2005;34:207-209.
71. Mehta SK, Stowe RP, Feiveson AH et al. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis 2000;182:1761-1764.
72. Appels A, Bar FW, Bar J et al. Inflammation, depressive symptomtology, and coronary artery disease. Psychosom Med 2000;62:601-605.
73. Sarid O, Anson O, Yaari A et al. Human cytomegalovirus salivary antibodies as related to stress. Clin Lab 2002;48:297-305.
74. Ganguli MY, Dodge HH et al. Depressive symptoms and cognitive decline in late life: A prospective epidemiological study. Arch Gen Psychiatry 2006;63:153-160.
75. Bassuk SS, Berkman LF, Wypij D. Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch Gen Psychiatry 1998;55:1073-1081.
76. Vercellotti GM. Overview of infections and cardiovascular diseases. J Allergy Clin Immunol 2001;108:S117-S120.